Works by van Tellingen, Olaf


Results: 34
    1
    2
    3
    4
    5
    6

    Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.

    Published in:
    2013
    By:
    • Tannous, Bakhos A;
    • Kerami, Mariam;
    • Van der Stoop, Petra M;
    • Kwiatkowski, Nicholas;
    • Wang, Jinhua;
    • Zhou, Wenjun;
    • Kessler, Almuth F;
    • Lewandrowski, Grant;
    • Hiddingh, Lotte;
    • Sol, Nik;
    • Lagerweij, Tonny;
    • Wedekind, Laurine;
    • Niers, Johanna M;
    • Barazas, Marco;
    • Nilsson, R Jonas A;
    • Geerts, Dirk;
    • De Witt Hamer, Philip C;
    • Hagemann, Carsten;
    • Vandertop, W Peter;
    • Van Tellingen, Olaf
    Publication type:
    journal article
    7

    Effects of the Selective MPSI Inhibitor MPSI-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 17, p. 1322, doi. 10.1093/jnci/djt168
    By:
    • Tannous, Bakhos A.;
    • Kerami, Mariam;
    • Van der Stoop, Petra M.;
    • Kwiatkowski, Nicholas;
    • Jinhua Wang;
    • Wenjun Zhou;
    • Kessler, Almuth F.;
    • Lewandrowski, Grant;
    • Hiddingh, Lotte;
    • Sol, Nik;
    • Lagerweij, Tonny;
    • Wedekind, Laurine;
    • Niers, Johanna M.;
    • Barazas, Marco;
    • Nilsson, R. Jonas A.;
    • Geerts, Dirk;
    • DeWitt Hamer^, Philip C.;
    • Hagemann, Carsten;
    • Vandertop, W. Peter;
    • Van Tellingen, Olaf
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16952-9
    By:
    • Fernandes Neto, João M.;
    • Nadal, Ernest;
    • Bosdriesz, Evert;
    • Ooft, Salo N.;
    • Farre, Lourdes;
    • McLean, Chelsea;
    • Klarenbeek, Sjoerd;
    • Jurgens, Anouk;
    • Hagen, Hannes;
    • Wang, Liqin;
    • Felip, Enriqueta;
    • Martinez-Marti, Alex;
    • Vidal, August;
    • Voest, Emile;
    • Wessels, Lodewyk F. A.;
    • van Tellingen, Olaf;
    • Villanueva, Alberto;
    • Bernards, René
    Publication type:
    Article
    20
    21

    A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 12, p. 1687, doi. 10.3390/ph17121687
    By:
    • Ntafoulis, Ioannis;
    • Koolen, Stijn L. W.;
    • van Tellingen, Olaf;
    • den Hollander, Chelsea W. J.;
    • Sabel-Goedknegt, Hendrika;
    • Dijkhuizen, Stephanie;
    • Haeck, Joost;
    • Reuvers, Thom G. A.;
    • de Bruijn, Peter;
    • van den Bosch, Thierry P. P.;
    • van Dis, Vera;
    • Gao, Zhenyu;
    • Dirven, Clemens M. F.;
    • Leenstra, Sieger;
    • Lamfers, Martine L. M.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity.

    Published in:
    PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273182
    By:
    • Pogacar, Ziva;
    • Johnson, Jackie L.;
    • Krenning, Lenno;
    • De Conti, Giulia;
    • Jochems, Fleur;
    • Lieftink, Cor;
    • Velds, Arno;
    • Wardak, Leyma;
    • Groot, Kelvin;
    • Schepers, Arnout;
    • Wang, Liqin;
    • Song, Ji-Ying;
    • van de Ven, Marieke;
    • van Tellingen, Olaf;
    • Medema, Rene H.;
    • Beijersbergen, Roderick L.;
    • Bernards, Rene;
    • Leite de Oliveira, Rodrigo
    Publication type:
    Article
    30
    31
    32

    MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 1, p. 58, doi. 10.1093/neuonc/noz151
    By:
    • Meel, Michaël H;
    • Navarro, Miriam Guillén;
    • Gooijer, Mark C de;
    • Metselaar, Dennis S;
    • Waranecki, Piotr;
    • Breur, Marjolein;
    • Lagerweij, Tonny;
    • Wedekind, Laurine E;
    • Koster, Jan;
    • Wetering, Marianne D van de;
    • Meeteren, Netteke Schouten-van;
    • Aronica, Eleonora;
    • Tellingen, Olaf van;
    • Bugiani, Marianna;
    • Phoenix, Timothy N;
    • Kaspers, Gertjan J L;
    • Hulleman, Esther
    Publication type:
    Article
    33
    34

    Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.

    Published in:
    Molecular Oncology, 2023, v. 17, n. 6, p. 964, doi. 10.1002/1878-0261.13377
    By:
    • Mulero‐Sánchez, Antonio;
    • Ramirez, Christel F. A.;
    • du Chatinier, Aimée;
    • Wang, Hui;
    • Koomen, Sofie J. I.;
    • Song, Ji‐Ying;
    • de Groot, Marnix H. P.;
    • Lieftink, Cor;
    • Bosma, Astrid;
    • Burylo, Artur;
    • van Tellingen, Olaf;
    • Beijersbergen, Roderick L.;
    • Wang, Cun;
    • Akkari, Leila;
    • Bernards, René;
    • Mainardi, Sara
    Publication type:
    Article